Compensation award — excluded from discretionary-purchase analysis.
Loading…
EVP Chief Patient & Ext Af Off
Disclosures on record
21
Companies involved
1
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$898K of Vertex Pharmaceuticals
Scheduled in advanceRoutine share withholding; mechanical by default.
Officer sold ~$9.21M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$5.51M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$4.8M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$3.4M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$2M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$1.27M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$861K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$427K of Vertex Pharmaceuticals
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.